Editorial: Special issue: Non-alcoholic fatty liver disease: From molecular basis to therapeutic advances

Narjes Nasiri-Ansari¹, Eva Kassi^{1

2}

Affiliations

¹ Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece.
² Endocrine Unit, 1st Department of Propaedeutic Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens, 11527, Athens, Greece.

Editorial

Narjes Nasiri-Ansari et al. Metabol Open. 2023.

. 2023 Jan 13:17:100229.

doi: 10.1016/j.metop.2023.100229. eCollection 2023 Mar.

Narjes Nasiri-Ansari¹, Eva Kassi^{1

2}

¹ Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece.
² Endocrine Unit, 1st Department of Propaedeutic Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens, 11527, Athens, Greece.

No abstract available

References

1. Androutsakos T., Nasiri-Ansari N., Bakasis A.D., Kyrou I., Efstathopoulos E., Randeva H.S., et al. SGLT-2 inhibitors in NAFLD: expanding their role beyond diabetes and cardioprotection. Int J Mol Sci. 2022;23(6) - PMC - PubMed
1. Nasiri-Ansari N., Androutsakos T., Flessa C.M., Kyrou I., Siasos G., Randeva H.S., et al. Endothelial cell dysfunction and nonalcoholic fatty liver disease (NAFLD): a concise review. Cells. 2022;11(16) - PMC - PubMed
1. Godoy-Matos A.F., Silva Junior W.S., Valerio C.M. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndrome. 2020;12:60. - PMC - PubMed
1. Akil L., Ahmad H.A. Relationships between obesity and cardiovascular diseases in four southern states and Colorado. J Health Care Poor Underserved. 2011;22(4 Suppl):61–72. - PMC - PubMed
1. Crisostomo T., Pardal M.A.E., Herdy S.A., Muzi-Filho H., Mello D.B., Takiya C.M., et al. Liver steatosis, cardiac and renal fibrosis, and hypertension in overweight rats: angiotensin-(3-4)-sensitive hepatocardiorenal syndrome. Metabol Open. 2022;14 - PMC - PubMed